Verzenio showed promising efficacy in high-grade meningiomas with CDK pathway or NF2 alterations, achieving progression-free survival at six months in 14 of 24 patients. Patients with NF2 alterations ...
Chronic itch has often been dismissed as a minor skin complaint; however, experts view it as a warning sign of deeper disease ...
In an interview with Targeted Oncology, lead author Brian M. Slomovitz, MD, discusses this move toward a "breast cancer model ...
JERSEY CITY, NJ, UNITED STATES, January 16, 2026 /EINPresswire.com/ -- New Jersey is experiencing a significant ...
From opening new therapeutic mechanisms to repairing neuronal damage, investigational molecules from Ventyx Therapeutics, AC ...
1d
Understanding Alcohol-Related Facial Puffiness: New WhiteSands Treatment Center Resource Published
WhiteSands Alcohol & Drug Rehab Tampa has published a new educational resource exploring the physiological effects of alcohol ...
1d
Holland Pathways Expands Wichita Campus With New Building to Increase Access to Addiction Treatment
Campus expansion supports growing community need and positions Holland Pathways for continued, sustainable growth Our ...
The GOG 3026 trial demonstrated that ribociclib and letrozole combination therapy achieved a 31% response rate and 84% ...
As elephants age in zoos and sanctuaries, acupuncture is joining veterinary care to manage pain, mobility, digestion, and ...
New recommendations prioritise multiparametric MRI, safer transperineal biopsy, and earlier escalation for high-risk prostate-specific antigen relapse.
Caring Cross, a 501(c)(3) non-profit dedicated to improving access to advanced therapies, and Boston Children's Hospital today announced a collaboration to provide a sustainable, affordable pathway ...
This article summarizes metabolic reprogramming in prostate cancer (PCa). Early PCa relies more on glycolysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results